参考文献/References:
［1］ Itoh S, Ikeda Y, Kawanaka H, et al. Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma［J］. Ann Surg Oncol, 2011, 18: 3650- 3656.
［2］ Bruix J, Sherman M. Management of hepatocellular carcinoma: an update［J］. Hepatology, 2011, 53: 1020- 1022.
［3］ Nishikawa H, Inuzuka T, Takeda H, et al. Percutaneous radiofre- quency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation［J］. J Gastroenterol, 2011, 46: 1418- 1426.
［4］ 经 翔， 丁建民， 王彦冬， 等． 射频消融和微波消融治疗肝癌的比较［J］． 介入放射学杂志， 2014， 23： 306- 310．
［5］ Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin［J］. AJR Am J Roent- genol, 2007, 188: 480- 488.
［6］ Qian GJ, Wang N, Shen Q, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies［J］. Eur Radiol, 2012, 22: 1983- 1990.
［7］ Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to milan criteria［J］. J Gastroenterol Hepatol, 2014, 29: 1500- 1507.
［8］ Lü MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retros- pective comparative study［J］. J Gastroenterol, 2005, 40: 1054- 1060.
［9］ 王 能， 钱国军， 沈 强， 等． 经皮肝穿刺射频治疗肝恶性肿瘤的严重并发症分析［J］． 中华肝胆外科杂志， 2011， 17： 186- 188．
［10］ Zhang M, Liang P, Cheng ZG, et al. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract［J］. Int J Hyperthermia, 2014, 30: 134- 141.
［11］ Ding J, Jing X, Liu J, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma［J］. Eur J Radiol, 2013, 82: 1379- 1384.
［12］ 许 贇， 王 能， 沈 强， 等． 经皮热消融治疗极早期肝癌的疗效及预后因素分析［J］． 中国普通外科杂志， 2015， 24： 945- 951．
［13］ 李晓峰， 钱国军， 张 磊， 等．微波高功率条件下消融原发性肝癌的初步研究［J］． 介入放射学杂志， 2011， 20： 974- 978．
相似文献/References:
[1]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良ＲＥＣＩＳＴ标准更可靠[J].介入放射学杂志,2012,(03):177.
. Ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ ｃｒｉｔｅｒｉｏｎ ｏｆ ｉｎｏｐｅｒａｂｌｅ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｍｏｄｉｆｉｅｄ ＲＥＣＩＳＴ ａｓ ａ ｍｏｒｅ ｒｅｌｉａｂｌｅ ｓｔａｎｄａｒｄ[J].journal interventional radiology,2012,(05):177.
[2]孙 磊,施海彬,刘 圣,等.肝细胞癌肝动脉门静脉分流形成的相关因素分析[J].介入放射学杂志,2012,(03):206.
,,et al.Ｔｈｅ ｆａｃｔｏｒｓ ｒｅｌａｔｅｄ ｔｏ ｔｈｅ ｆｏｒｍａｔｉｏｎ ｏｆ ａｒｔｅｒｉｏｐｏｒｔａｌ ｓｈｕｎｔｉｎｇ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ [J].journal interventional radiology,2012,(05):206.
[3]梁茂全,苏洪英. 肝癌化疗栓塞前后甲胎蛋白变化模式的临床意义[J].介入放射学杂志,2012,(04):333.
.Ｔｈｅ ｔｒａｎｓｆｏｒｍａｔｉｏｎ ｐａｔｔｅｒｎ ｏｆ ｓｅｒｕｍ аｆｅｔｏｐｒｏｔｅｉｎ ａｆｔｅｒ ｔｒａｎｓｃａｔｈｅｔｅｒ ａｒｔｅｒｉａｌ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａ： ｉｔｓ ｃｌｉｎｉｃａｌ ｓｉｇｎｉｆｉｃａｎｃｅ [J].journal interventional radiology,2012,(05):333.
[4]沈海洋,刘瑞宝,刘 岩,等. 肝右叶前、后段原发性肝癌TACE后VEGF及CD34的表达水平 ；[J].介入放射学杂志,2012,(06):469.
SHEN Hai- yang,LIU Rui- bao,LIU Yan,et al. The expression levels of vascular endothelial growth factor and CD34 in residual cancerous tissues of primary hepatocellular carcinoma located at anterior and posterior segments of right lobe liver after TACE[J].journal interventional radiology,2012,(05):469.
[5]彭辽河,胡晓燕,李 杰,等. 18F-FDG PET/CT显像在肝细胞癌TACE术后残留或复发病灶检出中的应用价值[J].介入放射学杂志,2012,(08):636.
PENG Liao- he,HU Xiao- yan,LI Jie,et al. Clinical application of 18F- FDG PET/CT imaging in detecting residual lesions or recurrence foci of hepatocellular carcinoma after TACE treatment[J].journal interventional radiology,2012,(05):636.
[6]王 会,胡继红,赵 卫. 骨肿瘤的消融治疗[J].介入放射学杂志,2012,(10):879.
WANG Hui,HU Ji- hong,ZHAO Wei.. Recent advances in ablation therapy of bone neoplasm[J].journal interventional radiology,2012,(05):879.
[7]姚雪松,闫 东,曾辉英,等. TACE联合索拉非尼治疗不能手术切除肝细胞肝癌50例[J].介入放射学杂志,2013,(05):381.
YAO Xue? song,YAN Dong,ZENG Hui? ying,et al. Ttransarterial chemoembolization combined with sorafenib for inoperable hepatocellular carcinoma： a clinical analysis of 50 cases[J].journal interventional radiology,2013,(05):381.
[8]陆小华,朱小庆,茅国新.肝细胞癌相关单核苷酸多态性的研究进展[J].介入放射学杂志,2013,(06):520.
LU Xiao? hua,ZHU Xiao? qing,MAO Guo? xin.. Hepatocellular carcinoma?蛳 related single nucleotide polymorphisms： recent advances in research[J].journal interventional radiology,2013,(05):520.
[9]赵 松,陈学春,龙清云,等. 经肝动脉化疗栓塞联合射频消融治疗肝细胞癌疗效荟萃分析[J].介入放射学杂志,2013,(11):908.
ZHAO Song,CHEN Xue? chun,LONG Qing? yun,et al. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma： a systematic review and Meta analysis[J].journal interventional radiology,2013,(05):908.
[10]易长虹,袁琳波,钱 坤,等.肝动脉灌注3-溴丙酮酸阻断大鼠肝癌能量代谢的实验研究[J].介入放射学杂志,2013,(12):1027.
YI Chang? hong,YUAN Lin? bo,QIAN Kun,et al. Hepatic arterial infusion of 3?蛳 bromopyruvate to block up the energy metabolism of hepatic carcinoma： an experimental study in rats[J].journal interventional radiology,2013,(05):1027.
[11]李晓峰,钱国军,张 磊,等. 微波高功率条件下消融原发性肝癌的初步研究[J].介入放射学杂志,2011,(12):974.
LI Xiao-feng,QIAN Guo-jun,ZHANG Lei,et al.Microwave ablation with high output power for the treatment of hepatocellular carcinoma: a preliminary study[J].journal interventional radiology,2011,(05):974.
[12]王晓维,付守忠,戴 锋,等.肝动脉栓塞化疗联合射频消融与联合微波消融治疗原发性肝癌的疗效和安全性比较 [J].介入放射学杂志,2016,(08):673.
WANG Xiao-wei,FU Shou-zhong,DAI Feng,et al.The curative effect and safety in treating primary hepatocellular carcinoma: comparison between TACE plus radiofrequency ablation and TACE plus microwave ablation [J].journal interventional radiology,2016,(05):673.
[13]周平盛,王延明,钱国军,等.微波消融治疗单发5 cm以下肝细胞肝癌预后及其影响因素分析 [J].介入放射学杂志,2017,(08):712.
ZHOU Pingsheng,WANG Yanming,QIAN Guojun,et al.Microwave ablation for solitary hepatocellular carcinoma sized less than 5 cm： analysis of prognosis and its influence factors[J].journal interventional radiology,2017,(05):712.
[14]周平盛,刘 晟,王 能,等.超声引导下微波消融治疗肝细胞癌术后肿瘤复发及其危险因素分析[J].介入放射学杂志,2022,31(12):1174.
ZHOU Pingsheng,LIU Sheng,WANG Neng,et al.Analysis of tumor recurrence and its risk factors after ultrasound-guided microwave ablation for hepatocellular carcinoma[J].journal interventional radiology,2022,31(05):1174.